Kejian Yang

Title: Kejian Yang: Innovator in Therapeutic Vaccines

Introduction

Kejian Yang is a notable inventor based in Worcester, MA (US). He has made significant contributions to the field of therapeutic vaccines, particularly in the treatment of herpes simplex virus type-2 infections. His innovative approach aims to enhance immunity against viral antigens, showcasing his dedication to advancing medical science.

Latest Patents

Kejian Yang holds 1 patent for his invention titled "Therapeutic vaccines for treating herpes simplex virus type-2 infections." This patent provides methods and kits designed to induce therapeutic immunity in animals against viral antigens, including herpes-simplex virus type 2. The invention outlines a method for treating animals with established HSV-2 infections by administering a therapeutic vaccine that includes a priming dose of nucleic acid encoding an HSV-2 antigen, an initial boosting dose of the protein form of the antigen encapsulated in liposomes, and subsequent boosting doses comprising both the nucleic acid and the liposomal-encapsulated protein antigen.

Career Highlights

Throughout his career, Kejian Yang has worked with various organizations, including Biomedical Research Models, Inc. and Oral Vaccine Technologies, Inc. His work in these companies has contributed to the development of innovative solutions in the field of vaccine research and development.

Collaborations

Kejian Yang has collaborated with notable colleagues such as Dennis L. Guberski and Barbara J. Whalen. These partnerships have furthered his research efforts and expanded the impact of his inventions.

Conclusion

Kejian Yang's contributions to therapeutic vaccines represent a significant advancement in the fight against viral infections. His innovative methods and dedication to research continue to inspire progress in the medical field.